139 related articles for article (PubMed ID: 1351466)
1. A kindred of multiple endocrine neoplasia type 2B.
Yamamoto S; Morimoto I; Fujihira T; Watanabe K; Zeki K; Yoshimoto K; Zeze F; Eto S
Endocrinol Jpn; 1992 Feb; 39(1):25-30. PubMed ID: 1351466
[TBL] [Abstract][Full Text] [Related]
2. Familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2B map to the same region of chromosome 10 as multiple endocrine neoplasia type 2A.
Lairmore TC; Howe JR; Korte JA; Dilley WG; Aine L; Aine E; Wells SA; Donis-Keller H
Genomics; 1991 Jan; 9(1):181-92. PubMed ID: 1672289
[TBL] [Abstract][Full Text] [Related]
3. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes.
Moley JF; Brother MB; Fong CT; White PS; Baylin SB; Nelkin B; Wells SA; Brodeur GM
Cancer Res; 1992 Feb; 52(4):770-4. PubMed ID: 1346584
[TBL] [Abstract][Full Text] [Related]
4. Allele loss on chromosome 10 and point mutation of ras oncogenes are infrequent in tumors of MEN 2A.
Okazaki M; Miya A; Tanaka N; Miki T; Yamamoto M; Motomura K; Miyauchi A; Mori T; Takai S
Henry Ford Hosp Med J; 1989; 37(3-4):112-5. PubMed ID: 2576939
[TBL] [Abstract][Full Text] [Related]
5. Hereditary medullary thyroid carcinoma: genetic annalysis of three related syndromes. Groupe d'Etude des Tumeurs a Calcitonine.
Sobol H; Narod SA; Schuffenecker I; Amos C; Ezekowitz RA; Lenoir GM
Henry Ford Hosp Med J; 1989; 37(3-4):109-11. PubMed ID: 2576938
[TBL] [Abstract][Full Text] [Related]
6. Deletion mapping on the distal third region of chromosome 1p in multiple endocrine neoplasia type IIA.
Yang KP; Nguyen CV; Castillo SG; Samaan NA
Anticancer Res; 1990; 10(2B):527-33. PubMed ID: 1972009
[TBL] [Abstract][Full Text] [Related]
7. Low incidence of loss of chromosome 10 in sporadic and hereditary human medullary thyroid carcinoma.
Nelkin BD; Nakamura Y; White RW; de Bustros AC; Herman J; Wells SA; Baylin SB
Cancer Res; 1989 Aug; 49(15):4114-9. PubMed ID: 2568166
[TBL] [Abstract][Full Text] [Related]
8. Loss of genes on chromosome 22 in medullary thyroid carcinoma and pheochromocytoma.
Takai S; Tateishi H; Nishisho I; Miki T; Motomura K; Miyauchi A; Kato M; Ikeuchi T; Yamamoto K; Okazaki M
Jpn J Cancer Res; 1987 Sep; 78(9):894-8. PubMed ID: 2889715
[TBL] [Abstract][Full Text] [Related]
9. Pheochromocytoma in multiple endocrine neoplasia.
Raue F; Frank K; Meybier H; Ziegler R
Cardiology; 1985; 72 Suppl 1():147-9. PubMed ID: 2865008
[TBL] [Abstract][Full Text] [Related]
10. Oncogene and growth factor expression in MEN 2 and related tumors.
Moley JF; Wallin GK; Brother MB; Kim M; Wells SA; Brodeur GM
Henry Ford Hosp Med J; 1992; 40(3-4):284-8. PubMed ID: 1362425
[TBL] [Abstract][Full Text] [Related]
11. [Medullary carcinoma of the thyroid: a case of multiple endocrine neoplasia type 2A].
Pati M; Sperti P; Magiar AV; Bonifacio V
Minerva Endocrinol; 1994 Mar; 19(1):29-32. PubMed ID: 7913514
[TBL] [Abstract][Full Text] [Related]
12. Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2.
Mulligan LM; Gardner E; Smith BA; Mathew CG; Ponder BA
Genes Chromosomes Cancer; 1993 Mar; 6(3):166-77. PubMed ID: 7682102
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of a family with the MEN-2A syndrome.
Haak HR; Nieuwenhuijzen Kruseman AC
Henry Ford Hosp Med J; 1987; 35(2-3):104-6. PubMed ID: 2891639
[No Abstract] [Full Text] [Related]
14. Multiple endocrine neoplasia syndrome type 2: the value of screening and central registration. A study of 15 kindreds in The Netherlands.
Vasen HF; Nieuwenhuijzen Kruseman AC; Berkel H; Beukers EK; Delprat CC; Van Doorn RG; Geerdink RA; Haak HR; Hackeng WH; Koppeschaar HP
Am J Med; 1987 Nov; 83(5):847-52. PubMed ID: 2890300
[TBL] [Abstract][Full Text] [Related]
15. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.
Lips CJ; Landsvater RM; Höppener JW; Geerdink RA; Blijham G; van Veen JM; van Gils AP; de Wit MJ; Zewald RA; Berends MJ
N Engl J Med; 1994 Sep; 331(13):828-35. PubMed ID: 7915822
[TBL] [Abstract][Full Text] [Related]
16. The importance of screening for medullary thyroid carcinoma in families of patients with MEN 2.
Frilling A; Goretzki PE; Bastian L; Roeher HD
Henry Ford Hosp Med J; 1989; 37(3-4):122-3. PubMed ID: 2576942
[TBL] [Abstract][Full Text] [Related]
17. Multiple endocrine neoplasia type 2A (MEN-2A): natural history, screening, and central registration.
Brouwers-Smalbraak GJ; Vasen HF; Struyvenberg A; Nieuwenhuijzen Kruseman AC; Helsloot MH; Lips CJ
Neth J Med; 1986; 29(4):111-7. PubMed ID: 2872602
[No Abstract] [Full Text] [Related]
18. Diagnosis, management, and pathogenetic studies in medullary thyroid carcinoma syndrome.
Samaan NA; Yang KP; Schultz P; Hickey RC
Henry Ford Hosp Med J; 1989; 37(3-4):132-7. PubMed ID: 2576946
[TBL] [Abstract][Full Text] [Related]
19. Pheochromocytoma in multiple endocrine neoplasia type II: an example of the two-hit theory of neoplasia.
Cerny JC; Jackson CE; Talpos GB; Yott JB; Lee MW
Surgery; 1982 Nov; 92(5):849-52. PubMed ID: 6127813
[TBL] [Abstract][Full Text] [Related]
20. Preoperative diagnosis of occult parathyroid hyperplasia by calcium infusion in patients with multiple endocrine neoplasia, type 2a.
Heath H; Sizemore GW; Carney JA
J Clin Endocrinol Metab; 1976 Aug; 43(2):428-35. PubMed ID: 950371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
